digital therapeutics

By Laura Lovett April 11, 2019
There is an app for just about everything, and the mental health space is no different. But industry experts warn that not all mental health apps are created equally. While there are exemplars of tools that have been clinically validated, there is also a slew of technologies that have not been tested at all.  “There are lot of opportunities for patients to receive bad care through apps right now...
By Dave Muoio April 10, 2019
A study published last month in JMIR Cardio demonstrated significant systolic and diastolic blood pressure reductions in hypertension patients who received a mobile app-based behavior change intervention. The investigation examined Better Therapeutics’ candidate digital therapeutic for cardiovascular disease, a daily-use app that encourages users to set and record their progress toward...
By Dave Muoio April 9, 2019
Although still in its earliest chapters, the story of digital thherapeutics is beginning to pick up steam. Just six months ago, that the first software-only therapeutic cleared by the FDA, Pear Therapeutics’ reSET, kicked off a commercial launch driven by the sales channels expertise of an established pharmaceutical partner. Proteus, meanwhile, recently expanded dealings with its long-time pharma...
By Laura Lovett April 4, 2019
Figuring out the best user experience can be a tricky process for any platform. But its particularly important in digital therapeutics, which some view as a disruptor to traditional pharmaceuticals.  Unlike medical drug makers, digital therapeutics companies have UX design to consider during the development of their products, Madhavi Jagdish, director of product designer at Pear Therapeutics,...
By Dave Muoio April 3, 2019
A staggering number of health apps are being released with each passing year, many of which could have a lasting impact on patients entering the health system with stress, anxiety or depression. That sheer volume of options comes at a cost, however, as many therapists and clinicians who are interested in recommending a digital tool or service to their patients simply don’t have the time to comb...
By Laura Lovett March 28, 2019
Within the last few years the FDA has undergone a metamorphosis when it comes to digital health regulations. Though many of these are not yet solidified, a recent report by PricewaterhouseCoopers (PwC) predicts that these changes could open new doors for pharmaceutical companies looking to jump into the digital arena.  “Changes made by the FDA have made it easier for digital health products to be...
By Dave Muoio March 7, 2019
Boston-based Akili Interactive Labs, maker of video game-like treatments for children with ADHD and autism spectrum disorder, has found a partner to help promote its digital therapeutic products in eastern Asia. Thanks to a new strategic partnership announced this morning, Osaka, Japan-based pharmaceutical company Shionogi will take over the commercialization, marketing, clinical development and...
Novartis
By Leontina Postelnicu March 4, 2019
Pharma giant Novartis and O2 innovation arm Wayra UK revealed last week that Virtue, TestCard and ExSeed would join its nine-month Health Hub accelerator programme. “After a rigorous judging day, I believe the innovations these three startups offer will make a significant difference to patients and the NHS,” said Novartis Market Access Director Fiona Bride. “I look forward to supporting them over...

Credit: Kaiku Health

By Leontina Postelnicu March 4, 2019
Helsinki-based health data science company Kaiku Health, which offers digital patient monitoring and patient-reported outcome services, has announced that is teaming up with Amgen to roll out digital symptom tracking for multiple myeloma, a type of bone marrow cancer. In collaboration with Turku University Hospital’s hematology unit in Finland, Kaiku Health developed in 2017 an adaptive algorithm...
By Dave Muoio January 24, 2019
The acceptability, safety, feasibility and preliminary efficacy of Meru Health’s digital therapeutic for depression will be evaluated in a new two-year investigation conducted by Stanford Medicine and VA Palo Alto Health Care System researchers. According to a clinicaltrials.gov listing, the research program will enroll older adults aged at least 40 years with depressive symptoms in two studies...
www.best-products.reviews

анаполон купить

Нашел в интернете популярный веб сайт , он рассказывает про гонадотропин https://ka4alka-ua.com/poslekursovoe/gonadotropin